Indeed, by the end of the culture period, we could show the appearance of cells expressing CD10+/CD19+/IgM+ in WT samples, absent in cultures from patients with XLA and rescued on gene editing. This evidence concerns the gene CD40LG and Bruton-type agammaglobulinemia.